1. Home
  2. AVXL vs LND Comparison

AVXL vs LND Comparison

Compare AVXL & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • LND
  • Stock Information
  • Founded
  • AVXL 2004
  • LND 2005
  • Country
  • AVXL United States
  • LND Brazil
  • Employees
  • AVXL N/A
  • LND N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • LND Farming/Seeds/Milling
  • Sector
  • AVXL Health Care
  • LND Consumer Staples
  • Exchange
  • AVXL Nasdaq
  • LND Nasdaq
  • Market Cap
  • AVXL 484.2M
  • LND 411.4M
  • IPO Year
  • AVXL N/A
  • LND 2006
  • Fundamental
  • Price
  • AVXL $7.45
  • LND $4.18
  • Analyst Decision
  • AVXL Strong Buy
  • LND
  • Analyst Count
  • AVXL 2
  • LND 0
  • Target Price
  • AVXL $43.00
  • LND N/A
  • AVG Volume (30 Days)
  • AVXL 1.6M
  • LND 67.6K
  • Earning Date
  • AVXL 11-25-2024
  • LND 11-22-2024
  • Dividend Yield
  • AVXL N/A
  • LND 6.61%
  • EPS Growth
  • AVXL N/A
  • LND 13.74
  • EPS
  • AVXL N/A
  • LND 0.54
  • Revenue
  • AVXL N/A
  • LND $216,814,626.00
  • Revenue This Year
  • AVXL N/A
  • LND $30.65
  • Revenue Next Year
  • AVXL N/A
  • LND $2.85
  • P/E Ratio
  • AVXL N/A
  • LND $7.63
  • Revenue Growth
  • AVXL N/A
  • LND N/A
  • 52 Week Low
  • AVXL $3.25
  • LND $4.02
  • 52 Week High
  • AVXL $10.45
  • LND $5.55
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 54.68
  • LND 43.52
  • Support Level
  • AVXL $7.55
  • LND $4.02
  • Resistance Level
  • AVXL $10.45
  • LND $4.19
  • Average True Range (ATR)
  • AVXL 0.84
  • LND 0.10
  • MACD
  • AVXL 0.08
  • LND 0.01
  • Stochastic Oscillator
  • AVXL 37.77
  • LND 41.89

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: